The Cross-Border Biotech Blog


Website | RSS | Twitter

"Biotechnology, health and business in Canada, the United States and worldwide."

Author: Jeremy Grushcow is a corporate lawyer at Ogilvy Renault in Toronto; Dani Peters is a consultant at Fabiani & Company in Washington, D.C.; Richard Chan is a science consultant at R&D Funding Management in Mississauga, Ontario, Canada; Peter van der Velden is the President and CEO of Lumira Capital in Toronto, and Beni Rovinski is Lumira Capital's managing director.

Related Categories: Health Law | Science & Technology Law | International | North America | Canada

Recent Posts from The Cross-Border Biotech Blog

Cross-Border Biotech Blog Relaunch
Posted: Apr 2, 2014, 8:00 am CDT
Monday Deal Review: March 31, 2014
Posted: Mar 31, 2014, 6:30 am CDT
Monday Deal Review: March 17, 2014
Posted: Mar 17, 2014, 6:30 am CDT
Monday Deal Review: March 10, 2014
Posted: Mar 10, 2014, 6:30 am CDT
Monday Deal Review: February 24, 2014
Posted: Feb 24, 2014, 6:01 pm CST
Monday Deal Review: February 10, 2014
Posted: Feb 10, 2014, 6:30 am CST
Monday Deal Review: February 3, 2014
Posted: Feb 3, 2014, 6:30 am CST
Monday Deal Review: January 27, 2014
Posted: Jan 27, 2014, 6:30 am CST
Monday Deal Review: January 20, 2014
Posted: Jan 20, 2014, 6:30 am CST